HeartSciences Inc
NASDAQ:HSCS

  • LAST PRICE
    2.6699
  • TODAY'S CHANGE (%)
    0.0499 (1.9046%)
  • Bid / Lots
    2.5000/ 8
  • Ask / Lots
    2.7100/ 1
  • Open / Previous Close
    2.6000 / 2.6200
  • Day Range
    2.6000
    2.7882
  • 52 Week Range
    2.3600
    29.0000
  • Volume
    5,260

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 13, 2024

      Show headlines and story abstract

    • 9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
      Companies Mentioned: HSCS

      Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=eh-9vHjEJoZxdUCq_esaxfDRekJD4rkcjzLmEoeSV1QlNSME6XVGQmWJWChXUTt2nHLlFOoe17hWqe0Zz6Ifq_JjtzGBPuGIWyf4e9OFC_IfPmJyx3PPoP36Ns9GRoHnQ_RUdfIOwK4W-CedUCiTi37K1kIQDqe4H2u2sffq6ZGtfTcDUsM2TGlV1tmsm32M2Yp6luplwJKUceX7xtoiRsK6g86dcSrJLWQnd0Rr1lY-Sfafm_qdmxOKCicooPNgdzquc-ZMjbp9LMC5tTpKtTjVDkA26qp4HIJEFQeJmIzF7Xb4wKwlGj78BIuwUODinao6KKxwmWJJjedbvh4vZtIbSqI1q2XYt6PzsdONlSWcWpNDnSDTe9z6Ynfj2dcmxt5L7G309O-e0sgWcDfKtg== Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has included AI-ECG technology in the 2025 Hospital Outpatient Prospective Payment System (OPPS) final rule under assignment APC 5734. This approval would allow outpatient settings to receive reimbursement for HeartSciences' MyoVista(R) wavECG(TM) algorithm and MyoVista(R) Insights(TM) low ejection fraction algorithm, upon FDA clearance. The payment rate is expected to be $125.

Peers Headlines

No documents available